US Patent Issued to Quest Diagnostics Investments on April 22 for "Mass spectrometric determination of tert-butyldimethylsilyl derivatized methylmalonic acid" (California Inventors)

ALEXANDRIA, Va., June 6 -- United States Patent no. 12,282,031, issued on April 22, was assigned to Quest Diagnostics Investments LLC.

"Mass spectrometric determination of tert-butyldimethylsilyl derivatized methylmalonic acid" was invented by Scott M. Goldman (Laguna Niguel, Calif.), Julie A. Neidich (Ladera Ranch, Calif.), Denise Salazar (Altadena, Calif.) and Thomas Lynn (Temecula, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to the detection of methylmalonic acid (MMA). In a particular aspect, the invention relates to methods for detecting derivatized methylmalonic acid (MMA) by mass spectrometry."

The patent was filed on Nov. 12, 2020, under Application No. 17/096,475.

*...